文献速递胃肠外科乳腺外科围术期管理与 ERAS

遗传性弥漫性胃癌综合征与CDH1基因作用综述

Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review.
PubMed 文献 · JAMA Surg · 2021-01-01

本文综述了CDH1基因胚系致病变异与遗传性弥漫性胃癌综合征及乳腺癌风险的关系。共识指南已扩大CDH1基因检测标准,推荐20岁起行预防性全胃切除术,拒绝手术者行年度内镜监测,女性30岁起行乳腺磁共振监测。早期弥漫性胃癌(T1a)的发病机制尚待深入研究。

要点

  • CDH1致病变异携带者20岁起推荐预防性全胃切除术。
  • 拒绝预防性全胃切除者应行年度内镜监测。
  • 女性CDH1变异携带者30岁起应行乳腺磁共振监测。

核心结论

  • CDH1基因胚系致病变异显著增加胃癌和乳腺癌风险,当前管理策略为预防性手术和加强监测。

研究设计与样本

  • 综述,围绕CDH1相关遗传性弥漫性胃癌综合征管理的最新议题进行讨论。

主要发现

  • 共识管理指南已扩大CDH1基因检测标准。
  • 任何致病性或可能致病性CDH1变异携带者从20岁起推荐预防性全胃切除术。
  • 拒绝预防性全胃切除术者推荐年度监测内镜。
  • 携带CDH1变异的女性应从30岁起开始乳腺磁共振成像监测。

关键数值与推荐

  • 预防性全胃切除术推荐用于任何致病性或可能致病性CDH1变异携带者,从20岁开始。
  • 年度监测内镜推荐用于推迟预防性全胃切除术者。
  • 女性CDH1变异携带者从30岁起开始乳腺磁共振成像监测。

临床怎么用

  • 对CDH1致病变异携带者,从20岁起评估并推荐预防性全胃切除术。
  • 对拒绝或推迟手术的携带者,安排年度内镜监测。
  • 对女性CDH1变异携带者,从30岁起启动乳腺磁共振成像监测。

局限性

  • 早期(T1a)弥漫性胃癌进展为晚期胃癌的发病机制尚不清楚,需进一步研究以制定治疗和预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Inherited variants in the tumor suppressor gene CDH1 are associated with an increased risk of gastric and breast cancers. This review aims to address the most current topics in management of the hereditary diffuse gastric cancer syndrome attributed to CDH1. OBSERVATIONS: Consensus management guidelines have broadened genetic testing criteria for CDH1. Prophylactic total gastrectomy is recommended for any pathogenic or likely pathogenic CDH1 variant carrier starting at the age of 20 years. Annual surveillance endoscopy is recommended to those who defer prophylactic total gastrectomy. Women with a CDH1 variant should initiate magnetic resonance imaging breast surveillance starting at age 30 years. Further research is needed to understand the pathogenesis of early-stage gastric cancers (T1a), which are pathognomonic of hereditary diffuse gastric cancer syndrome, that lead to advanced gastric cancer to develop both treatment and prevention strategies for this patient population. CONCLUSIONS AND RELEVANCE: The heritable CDH1 gene mutation is of importance to today's surgeons because it is associated with a substantial increased risk of developing both gastric and breast cancers. Management of this cancer syndrome currently uses prophylactic surgery and enhanced cancer surveillance strategies.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Gamble LA, Heller T, Davis JL, et al. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review. JAMA Surg. 2021. PMID: 33404644. doi:10.1001/jamasurg.2020.6155

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。